{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    19,
    20,
    21,
    22,
    23,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Upadacitinib",
        "type": {
          "id": "1f7c4615-a458-487a-8a1e-4379456df44b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "14886827-6ef7-442a-a201-05fab6a22c1e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Selective JAK1 inhibitor for the treatment of active psoriatic arthritis.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "3d37ddb2-568f-410f-8c67-6500cb39b3bd",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "522f69e8-3049-43a4-85b6-c7b7ba614dac",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for upadacitinib.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Methotrexate (MTX)",
        "type": {
          "id": "77b00591-021d-4c11-9402-0c31f5d6ecb1",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "e2d25cef-47ff-42c5-a561-d93c055e867d",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 25 mg/week.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Sulfasalazine (SSZ)",
        "type": {
          "id": "17f34d07-d5be-43c2-97bc-3f030d45bb82",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "4fb6b365-4919-4ae4-99c4-d358a90465de",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 3000 mg/day."
      },
      {
        "id": "int_5",
        "name": "Leflunomide (LEF)",
        "type": {
          "id": "cbfe640d-bf60-427b-a275-25765f045e2f",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "9a7520ae-9403-422c-b57e-8ef98b0ffb11",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 20 mg/day."
      },
      {
        "id": "int_6",
        "name": "Apremilast",
        "type": {
          "id": "774ed047-deb4-4bbd-bcbd-2f0e722632c9",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "a772ed08-dc9d-4293-b63d-e23646df6e72",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 60 mg/day."
      },
      {
        "id": "int_7",
        "name": "Hydroxychloroquine (HCQ)",
        "type": {
          "id": "40c2d488-98bc-46bc-b9ac-a24e134e249b",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "8f880ac2-bf5f-48f5-aabc-a0d695733188",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 400 mg/day."
      },
      {
        "id": "int_8",
        "name": "Bucillamine",
        "type": {
          "id": "cdd20b28-462c-4fec-9e26-6ec4e1a4cf93",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "9b01fdce-0f95-4dbe-bacb-edcbf98588fc",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 300 mg/day."
      },
      {
        "id": "int_9",
        "name": "Iguratimod",
        "type": {
          "id": "e561f16c-a2b9-4d43-b5c8-01f3a6c04751",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "1a40b8b9-19a6-40ca-a59e-2477c9eed63d",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted non-biologic DMARD at doses ≤ 50 mg/day."
      },
      {
        "id": "int_10",
        "name": "Folic acid",
        "type": {
          "id": "c9bad058-ec20-4148-ad9e-717f25b586f4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "a320fdf8-191f-4463-8f35-b101aed05d7e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required dietary supplement for all subjects taking MTX."
      },
      {
        "id": "int_11",
        "name": "NSAIDs",
        "type": {
          "id": "bdde38ea-2be4-4d06-a818-22b013d73015",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "56e06108-f087-4481-988b-b8b3808217c3",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "id": "int_12",
        "name": "Acetaminophen/paracetamol",
        "type": {
          "id": "26f93041-e2f8-4f51-be1b-448e86642ecf",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "f72d4f58-609a-40c7-8b6c-f98f03af5295",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "id": "int_13",
        "name": "Oral corticosteroids",
        "type": {
          "id": "0f3816e9-4834-421f-a883-0b512b1ec98d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "27e1f7a0-6063-422b-bf63-8031a8d3e234",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted at stable doses equivalent to prednisone ≤ 10 mg/day."
      },
      {
        "id": "int_14",
        "name": "Low-potency opiates",
        "type": {
          "id": "5176dbbd-ba86-4214-a93a-044195c84d3e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "75216f57-0325-4b34-8510-2a606e04c654",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Tramadol or combination of acetaminophen and codeine/hydrocodone permitted."
      },
      {
        "id": "int_15",
        "name": "Intra-articular corticosteroid injection",
        "type": {
          "id": "8186f44b-ec79-414e-afc8-b49e45928779",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "6223a15c-1362-418c-a27b-9464049a2831",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Offered to non-responders at Week 16 for one peripheral joint/site."
      },
      {
        "id": "int_16",
        "name": "Strong CYP3A inhibitors/inducers",
        "type": {
          "id": "6ab25be0-ee01-4ad4-a182-0e85a7a16f74",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "71b0afaf-a782-4d6e-bd49-5f1e5a7a6529",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited from Screening through the last dose of study drug."
      },
      {
        "id": "int_17",
        "name": "Live vaccines",
        "type": {
          "id": "5c8532f6-bd50-41fe-9bdf-7ad6103462dd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b21ed082-2da8-4851-b2f8-16dd74388f10",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 4 weeks (8 weeks in Japan) prior to Baseline and during study."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Upadacitinib (ABT-494)",
        "administrableDoseForm": {
          "id": "cc83a3de-573a-4633-844c-a300991a3cf6",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "114882e9-7a04-40bd-a074-19cbd49f91c8",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "5d17058a-d899-4f09-a6cb-c8db5c370c91",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "15 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_2",
        "name": "Upadacitinib (ABT-494)",
        "administrableDoseForm": {
          "id": "c770fead-112e-4d0e-96ac-33576e0642b4",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "34f41ed9-6f6a-4d6b-8c2f-306c97c8645a",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "aaca08ec-9fe6-424e-ab1f-ff3251488803",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "30 mg",
        "manufacturer": "AbbVie"
      },
      {
        "id": "prod_3",
        "name": "Placebo",
        "administrableDoseForm": {
          "id": "35bb3425-1656-4232-ac00-c59ff9df0775",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "7e0ffa17-bbe9-4b6b-953a-81133ee26f11",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "e2e9adca-591f-4444-9ad7-3b19ef373fad",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Matching",
        "manufacturer": "AbbVie"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Upadacitinib 15 mg QD",
        "instanceType": "Administration",
        "dose": "15 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Up to approximately 3 years"
      },
      {
        "id": "admin_2",
        "name": "Upadacitinib 30 mg QD",
        "instanceType": "Administration",
        "dose": "30 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until Protocol Amendment 8 approval (then switched to 15 mg)"
      },
      {
        "id": "admin_3",
        "name": "Placebo QD",
        "instanceType": "Administration",
        "dose": "1 tablet",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "24 weeks"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Upadacitinib",
        "instanceType": "Substance",
        "description": "Janus Kinase (JAK) 1 inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 17,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Upadacitinib",
        "role": "Investigational Product",
        "description": "Selective JAK1 inhibitor for the treatment of active psoriatic arthritis."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for upadacitinib."
      },
      {
        "name": "Methotrexate (MTX)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 25 mg/week."
      },
      {
        "name": "Sulfasalazine (SSZ)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 3000 mg/day."
      },
      {
        "name": "Leflunomide (LEF)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 20 mg/day."
      },
      {
        "name": "Apremilast",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 60 mg/day."
      },
      {
        "name": "Hydroxychloroquine (HCQ)",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 400 mg/day."
      },
      {
        "name": "Bucillamine",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 300 mg/day."
      },
      {
        "name": "Iguratimod",
        "role": "Background Therapy",
        "description": "Permitted non-biologic DMARD at doses ≤ 50 mg/day."
      },
      {
        "name": "Folic acid",
        "role": "Concomitant Medication",
        "description": "Required dietary supplement for all subjects taking MTX."
      },
      {
        "name": "NSAIDs",
        "role": "Concomitant Medication",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "name": "Acetaminophen/paracetamol",
        "role": "Concomitant Medication",
        "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
      },
      {
        "name": "Oral corticosteroids",
        "role": "Concomitant Medication",
        "description": "Permitted at stable doses equivalent to prednisone ≤ 10 mg/day."
      },
      {
        "name": "Low-potency opiates",
        "role": "Concomitant Medication",
        "description": "Tramadol or combination of acetaminophen and codeine/hydrocodone permitted."
      },
      {
        "name": "Intra-articular corticosteroid injection",
        "role": "Rescue Medication",
        "description": "Offered to non-responders at Week 16 for one peripheral joint/site."
      },
      {
        "name": "Strong CYP3A inhibitors/inducers",
        "role": "Concomitant Medication",
        "description": "Prohibited from Screening through the last dose of study drug."
      },
      {
        "name": "Live vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited within 4 weeks (8 weeks in Japan) prior to Baseline and during study."
      }
    ],
    "products": [
      {
        "name": "Upadacitinib (ABT-494)",
        "doseForm": "Tablet",
        "strength": "15 mg",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Upadacitinib (ABT-494)",
        "doseForm": "Tablet",
        "strength": "30 mg",
        "manufacturer": "AbbVie"
      },
      {
        "name": "Placebo",
        "doseForm": "Tablet",
        "strength": "Matching",
        "manufacturer": "AbbVie"
      }
    ],
    "substances": [
      {
        "name": "Upadacitinib",
        "description": "Janus Kinase (JAK) 1 inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Upadacitinib 15 mg QD",
        "dose": "15 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Up to approximately 3 years"
      },
      {
        "name": "Upadacitinib 30 mg QD",
        "dose": "30 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Until Protocol Amendment 8 approval (then switched to 15 mg)"
      },
      {
        "name": "Placebo QD",
        "dose": "1 tablet",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "24 weeks"
      }
    ],
    "devices": []
  }
}